State-of-the-Art Advances in T2DM Management: Expert Analysis of New & Emerging GLP-1 Receptor Agonists – featuring Drs. Thomas Blevins, Anne Peters and Carol Wysham. For more information please visit http://www.cardiometabolichealth.org/2013/agenda.asp
Supported by an educational grant from Lilly USA, LLC
Cardiometabolic Risk in Racial/Ethnic Minorities: Unique Aspects and Practical Solutions – featuring Drs. Keith C. Ferdinand, JoAnne Foody, Gary Pu…ckrein, Laurence Sperling and Tracy Wang. For more information please visit http://www.cardiometabolichealth.org/2013/agenda.asp
This symposium is sponsored by the American College of Cardiology
ALTERNATE PATHWAYS FOR THE MANAGEMENT OF TYPE 2 DIABETES: Expert Analysis on Targeting Dopamine & the CNS for Glycemic Control & CV Risk Reduction – featuring Drs. David S. H. Bell, Samuel Dagogo-Jack, J. Michael Gaziano and Jay Skyler. This symposium is supported by an educational grant from Santarus, Inc.
To learn more about this exciting addition to the 2013 CMHC Program Agenda, please visit our website: http://www.cardiometabolichealth.org/2013/agenda.asp.
State-of-the-Art Management of Severe and Familial Hypercholesterolemia: Examining the Role of Antisense Therapy in Clinical Practice- featuring Drs. P. Barton Duell, Peter Jones, Patrick M. Moriarty, and Evan Stein.
This symposium is supported by an educational grant from Genzyme, A SANOFI COMPANY
To learn more about this exciting addition to the 2013 CMHC Program Agenda, please visit our website: http://www.cardiometabolichealth.org/2013/agenda.asp
New Strategies for Obesity Management & Cardiometabolic Risk Reduction: Expert Perspectives on Novel Therapies Targeting the CNS – featuring Drs. Louis Aronne, Harold Bays, Lee M. Kaplan and Steven Smith. This symposium is supported by an educational grant from Eisai Inc.
To learn more about this exciting addition to the 2013 CMHC Program Agenda, please visit our website: http://www.cardiometabolichealth.org/2013/agenda.asp